{
    "medicine_id": "dae11a2bd3625ff81b1bc33c754aacb05a65f906",
    "platform_id": "DB11063",
    "metadata": {
        "name": "Avitears 10 mg 1mL Solution drops",
        "composition": "10 mg 1mL Polysorbate 80",
        "clinical_particulars": {
            "therapeutic_indications": "It is used as a solubilizer antimicrobial preservative and disinfectant L1853",
            "contraindications": {
                "disease": "Acute oral toxicity LD50 25000 mg kg in Mouse MSDS In general study results of the polysorbates demonstrated no carcinogenicity and genotoxicity In repeated dose toxicity studies diarrhea was observed as the major symptom of toxicity L1856 Some studies however show conflicting findings In a 2 year dietary study of polysorbate 80 in rats a higher incidence of adrenal medullary pheochromocytomas was found mainly in male rats L1856 Polysorbate 80 is used as a solubilizing agent in IV infusions of the antiarrhythmic drug amiodarone Rare case reports of liver toxicity have been published suggesting polysorbate 80 may contribute to liver toxicity with the IV formulation of amiodarone The package labeling of amiodarone warns that polysorbate 80 is also known to leach DEHP dioctyl phthalate from PVC and dosing recommendations must be followed closely L1852 It was found that maternal toxicities such as loose stool suppression of weight gain and reduced intake were seen and poor lactation was noted in some studies of mother rats administered 7 5 solutions of polysorbates L1856",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Polysorbates are widely used to protect biological drug products from protein unfolding aggregation and precipitation during both shipping and handling The polysorbates are amphipathic nonionic surfactants made of fatty acid esters of polyoxyethylene sorbitan Polysorbate 80 is one of the most common surfactants currently used in the formulation of protein based biopharmaceuticals A32234",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}